Muscarinic receptor subtype determines vulnerability to oxidative stress in COS-7 cells

Free Radical Biology and Medicine

Volumn 32, Issue 2, 2002, Pages 153-161

  Joseph, J A ^a   Fisher, D R ^a   Strain, J ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Calcium buffering; COS 7 cells; Dopamine; Free radicals; Muscarinic receptor subtype; PBN

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CONOTOXIN; DOPAMINE; MUSCARINIC RECEPTOR; NIFEDIPINE; NITRONE; OXOTREMORINE; RECEPTOR SUBTYPE; TROLOX C;

AGING; ANIMAL CELL; ARTICLE; BRAIN REGION; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL STRAIN COS7; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE; GENETIC TRANSFECTION; NERVE FUNCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGING; ANIMALS; ANTIOXIDANTS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CHROMANS; CONOTOXINS; COS CELLS; DOPAMINE; MUSCARINIC AGONISTS; NIFEDIPINE; OXIDATIVE STRESS; OXOTREMORINE; PROTEIN ISOFORMS; REACTIVE OXYGEN SPECIES; RECEPTORS, MUSCARINIC; SENSITIVITY AND SPECIFICITY; TRANSFECTION; WATER-ELECTROLYTE BALANCE;

EID: 0037081441     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(01)00779-1     Document Type: Article

References (84)

1. Oxidative metabolism
2. Oxidative stress leading to loss of critical proteases in Alzheimer's disease. An alternative view of the etiology of AD
3. Copernicus revisited: Amyloid beta in Alzheimer disease
4. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease
5. Changes in memory processing with age
6. The effects of aging and oxidative stress on psychomotor and cognitive behavior
7. Rodent models of memory dysfunction in Alzheimer's disease and normal aging: Moving beyond the cholinergic hypothesis
8. Psychomotor and spatial memory performance in aging male Fischer 344 rats
9. Neurochemical changes in the aging human brain: Implications for behavioral impairment and neurodegenerative disease
10. Age-related changes in the nigrostriatum: A behavioral and biochemical analysis
11. Dopamine modulation of responses mediated by excitatory amino acids in the neostriatum
12. Effects of bifemelane on muscarinic receptors and choline acetyltransferase in the brains of aged rats following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries
13. Selective cross activation/inhibition of second messenger systems and the reduction of age-related deficits in the muscarinic control of dopamine release from perifused rat striata
14. Age-related changes of cholinergic markers in the rat brain
15. Influence of age on hypoxia/reoxygenation-induced DNA fragmentation and bcl-2, bcl-xl, bax and fas in the rat heart and brain
16. Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses
17. Excitotoxins, aging, and environmental neurotoxins: Implications for understanding human neurodegenerative diseases
18. Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: Increased susceptibility with aging
19. +-evoked dopamine release from superfused striatal slices: Reversals by PBN or Trolox
20. An introduction to the free radical hypothesis in Parkinson's disease
21. Aging- and oxygen-induced modifications in brain biochemistry and behavior
22. Cellular defenses against damage from reactive oxygen species
23. Bcl-2 protein expression in aged brain and neurodegenerative diseases
24. Oxidant injury in PC-12 cells - A possible model of calcium "dysregulation" in aging: II. Interactions with membrane lipids
25. The role of glutathione, membrane sphingomyelin, and its metabolites in oxidative stress-induced calcium "dysregulation" in PC12 cells
26. Parameters of calcium homeostasis in normal neuronal ageing
27. Up-regulation of alpha1D Ca2+ channel subunit mRNA expression in the hippocampus of aged F344 rats
28. Secondary mechanisms in neuronal trauma
29. Intracellular calcium accumulation during the evolution of hypoxic-ischemic brain damage in the immature rat
30. Apoptotic and antiapoptotic mechanisms in stroke
31. Selective decline of 5-HT1A receptor binding sites in rat cortex, hippocampus and cholinergic basal forebrain nuclei during aging
32. Oxidative-stress-dependent up-regulation of Bcl-2 expression in the central nervous system of aged Fisher-344 rats
33. Region-specific downregulation of free intracellular calcium in the aged rat brain
34. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain
35. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: A deficit at the ligand-muscarinic receptor interface?
36. +-evoked release of endogenous striatal dopamine. An indicator of altered cholinergic-Dopaminergic reciprocal inhibitory control in senescence
37. M GTPase activity in aging and Alzheimer's disease: Implications for impaired signal transduction
38. Alzheimer's, ageing and amyloid: An absurd allegory?
39. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging
40. Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain
41. Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease
42. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: Identification and cellular localization
43. Cerebral cortical muscarinic cholinergic and N-methyl-D-aspartate receptors mediate increase in cortical blood flow elicited by chemical stimulation of periaqueductal gray matter
44. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling
45. Nutritional factors in cerebral aging and dementia: Epidemiological arguments for a role of oxidative stress
46. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia
47. Use of a sandwich enzyme-linked immunosorbent assay strategy to study mechanisms of G protein-coupled receptor assembly
48. Cytotoxic and genotoxic potential of dopamine
49. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine
50. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine
51. In vivo autoxidation of dopamine in guinea pig striatum increases with age
52. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections
53. Identification of a family of muscarinic acetylcholine receptor genes
54. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes
55. Effects of extracellular ATP on Fe(2+)- induced cytotoxicity in PC-12 cells
56. Reduced calcium uptake by rat brain mitochondria and synaptosomes in response to aging
57. 2+ indicators with greatly improved fluorescence properties
58. Oxidant injury in PC-12 cells: A possible model of calcium "dysregulation" in aging: I. Selectivity of antioxidant protection
59. Effects of reactive oxygen species on brain synaptic plasma membrane Ca(2+)-ATPase
60. Calcium dysregulation in neuronal aging and Alzheimer's disease: History and new directions
61. Age-associated changes in Ca(2+)-dependent processes: Relation to hippocampal synaptic plasticity
62. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys
63. Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing
64. What counts in brain aging? Design-based stereological analysis of cell number
65. Numbers of meynert and layer IVB cells in area V1: A stereologic analysis in young and aged macaque monkeys
66. Tocopherol-binding proteins: Their function and physiological significance
67. Antioxidant behaviors of vitamin E analogues in unilamellar vesicles
68. Effects of the spin trap-alpha-phenyl-N-tert-butyl nitrone (PBN) in transient forebrain ischaemia in the rat
69. Role and mechanisms of secondary mitochondrial failure
70. 2: Calcium-dependent activation of the EGF receptor/ERK pathway
71. Neurotoxic effect of L-2-chloropropionic acid on primary cultures of rat cerebellar granule cells
72. Antioxidant effects of calcium antagonists in rat brain homogenates
73. Reactive oxygen species and antioxidant status in essential arterial hypertension during therapy with dihydropyridine calcium channel antagonists
74. Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation
75. Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: Light and electron microscopic immunocytochemistry using subtype-specific antibodies
76. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain
77. Membrane and receptor modifications of oxidative stress vulnerability in aging. Nutritional considerations
78. Effects of age on dopamine transporters in healthy humans
79. Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging
80. Receptor- and age-selective effects of dopamine oxidation on receptor-G protein interactions in the striatum
81. Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: An in vivo electrochemical study
82. Say NO to Alzheimer's disease: The putative links between nitric oxide and dementia of the Alzheimer's type
83. Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation
84. Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells